Elsemieke S. De Vries

Zwolle, OV, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study.

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study.

Journal: Journal of gastroenterology

Published: January 04, 2026

A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation.

A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation.

Journal: Alimentary pharmacology & therapeutics

Published: November 13, 2025

Effectiveness and Tolerability of Bezafibrate in Primary Biliary Cholangitis: A Nationwide Real-World Study.

Effectiveness and Tolerability of Bezafibrate in Primary Biliary Cholangitis: A Nationwide Real-World Study.

Journal: The American journal of gastroenterology

Published: June 11, 2025

Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.

Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.

Journal: The American journal of gastroenterology

Published: June 11, 2025

Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy.

Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy.

Journal: JHEP reports : innovation in hepatology

Published: November 17, 2023

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.

Journal: Trials

Published: October 04, 2023

Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis.

Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 14, 2022

Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.

Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: May 16, 2020

Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.

Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.

Journal: Gastroenterology

Published: March 20, 2020

IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer.

IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer.

Journal: JHEP reports : innovation in hepatology

Published: January 12, 2020

Reply to: "UDCA therapy in intrahepatic cholestasis of pregnancy?"

Reply to: "UDCA therapy in intrahepatic cholestasis of pregnancy?"

Journal: Journal of hepatology

Published: November 22, 2019

Ursodeoxycholic acid in pregnancy?

Ursodeoxycholic acid in pregnancy?

Journal: Journal of hepatology

Published: May 26, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026